• 대한본초학회지
• /
• 제28권1호
• /
• pp.23-31
• /
• 2013

Objectives : The purpose of this study was to determine the anti-obesity effect and molecular mechanism of YY312, a herbal extract composed of Imperatae Rhizoma, Citri Unshius Pericarpium Immaturus, and Evodiae Fructus, on a high-fat diet-induced animal model and on 3T3-L1 cells. Methods : C57BL/6 mice were fed for 6 weeks with a normal diet or a high-fat diet (HFD). Then they orally administered daily with 300 mg/kg YY312 for next 10 weeks. Body weight and food consumption were recorded weekly and daily, respectively. Tissue weights, serum lipid, and glucose levels were analyzed at the end of the study. Additionally, the effects of YY312 on adipocyte differentiation in 3T3-L1 cells were examined. After differentiating 3T3-L1 cells were treated with YY312, Oil-red O staining, RT-PCR, and Western blotting were performed for lipid accumulation, mRNA expression of adipogenesis gene, and AMP-activated protein kinase (AMPK) phosphorylation, respectively. Results : YY312-administered mice showed a significant reduction of body weights and abdominal adipose tissue weights. YY312 also reduced the serum levels of triglycerides and total cholesterol, compared with the HFD group. Treatment with YY312 inhibited lipid accumulation and blocked expression of adipogenic transcription factors and lipogenesis genes, including peroxisome proliferator-activated receptor ${\gamma}$, CCAT/enhancer binding protein ${\alpha}$ and fatty acid synthase. YY312 increased AMPK phosphorylation in 3T3-L1 adipocytes. Conclusions : This study showed that herbal extract YY312 has an anti-obesity effect in vitro and in vivo. Thus, YY312 could be developed as a supplement for reduction of body weight gain induced by an HFD.

• 대한본초학회지
• /
• 제33권2호
• /
• pp.69-77
• /
• 2018

Objectives : Daesiho-tang (DSHT) has been widely used in the treatment of cerebral infarct in traditional medicine. However, there was not report on the anti-obesity-related diseases efficacy of DSHT. In this study, we investigated the effects for the new formulation of DSHT, on the adipocyte differentiation cycle in 3T3-L1 cells. Methods : 3T3-L1 cells were treated with DSHT (50, 100, $200{\mu}g/m{\ell}$) during differentiation for 6 days. Also, the inhibitory effect of DSHT against 3T3-L1 adipogenesis was evaluated in various stage of adipogenesis such as early (0-2day), intermediate (2-4day), and terminal stage (4-6day). The accumulation of lipid droplets was determined by Oil Red O staining. and, the expressions of genes related to adipogenesis were measured by RT-PCR and Western blot analyses. Results : DSHT showed inhibitory activity on adipocyte differentiation at 3T3-L1 preadipocytes without affect cell toxicity as assessed by measuring fat accumulation and adipogenesis. In addition, DSHT significantly reduced the expression levels of several adipocyte marker genes including proliferator activated $receptor-{\gamma}$ ($PPAR-{\gamma}$) and CCAAT/ enhancer-binding $protein-{\alpha}$ ($C/EBP-{\alpha}$). Also, the anti-adipogenic effect of DSHT was strongly limited in the intermediate (2-4 day), terminal stage (4-6 day) of 3T3-L1 adipogenesis. In addition, the DSHT treatment down- regulated mRNA expression levels of $PPAR-{\gamma}$,, $C/EBP-{\alpha}$ in mature 3T3-L1 adipocytes. Conclusions : These results suggest that, the ability of DSHT has inhibited overall adipogenesis and lipid accumulation in the 3T3-L1 cells. The new formulation of DSHT may be a promising medicine for the treatment of obesity and related metabolic disorders.

• 생명과학회지
• /
• 제32권7호
• /
• pp.523-531
• /
• 2022

본 연구에서는 한방복합추출물(마황, 창출, 석고, 카카오닙스)을 제조하여, 추출물에 대한 항산화 활성 및 지방세포형성억제 활성을 확인하고자 하였다. 한방복합물의 항산화 활성을 확인하기 위하여 DPPH, ABTS⁺ radical 소거능 및 xanthine oxidase 저해 활성을 측정한 결과 추출물 1,000 ㎍/ml 농도에서 각각 75.0, 100.8 및 79.5%로 높은 소거능을 나타내었다. 3T3-L1 지방전구세포에서 한방복합물에 의한 지방형성 및 지방세포 분화 억제를 조사한 결과 0~50 ㎍/ml 농도에서 3T3-L1 세포 생존율에 영향을 미치지 않았다. 3T3-L1 지방전구세포에서 25, 50 및 75 ㎍/ml의 한방복합물 처리는 농도 의존적으로 지질 축적을 억제하였다. Western blot 실험 결과 한방복합물은 MDI 유도 분화 3T3-L1 세포에서 분화 전사인자인 PPARγ, C/EBPα 을 75 ㎍/ml 농도에서 각 44.2, 76.6% 억제함을 나타내었다. 또한, 지방산 합성 조절 인자인 FAS의 발현도 억제하였다. 이와 같은 결과를 바탕으로 본 연구는 항비만 기능성 소재로서 한방복합추출물의 활용 가능성을 제시해 줄 수 있을 것으로 사료 된다.

• 대한의용생체공학회:의공학회지
• /
• 제41권3호
• /
• pp.138-145
• /
• 2020

Adipocytes are the main constituent of adipose tissue. Understanding the molecular basis of adipogenesis is pivotal to finding the therapeutic targets for treatment of obesity. Melatonin is associated with obesity and its mechanism is currently under intensive investigation. The objective of this study was to investigate the effect of melatonin on adipogenesis in differentiating preadipocytes. 3T3-L1 preadipocytes were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 5% calf serum at 37℃ with 5% CO₂ in a humidified incubator. Differentiation was induced using DMEM with 10% fetal bovine serum supplemented with MDI two days after cell confluence (day 0). Cells were treated with 0, 10 and 100 μM melatonin on either day 0 or day 5. 72 hours after each treatment, lipid accumulation was measured by oil red O staining. Proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to membranes. As a result, lipid accumulation decreased with melatonin treatment. ERK pathway, activated when differentiation is induced, also decreased with an increase in melatonin concentration. Furthermore, the expression of key adipogenic factors, C/EBPα, C/EBPβ, and PPARγ, were reduced by melatonin treatment. These results imply that melatonin may inhibit the process of adipogenesis and may have a role as a new anti-obesity agent.

• 대한화장품학회지
• /
• 제36권2호
• /
• pp.145-150
• /
• 2010

일반적으로 보석란으로 알려진 금선련은 대만에서 폐나 간의 질병 및 발열이나 두통 치료를 위한 전통식물약제로 사용되어 왔다. 본 연구에서는 생물반응장치를 이용하여 조직배양된 금선련 식물체에 대하여 화장품 성분으로써 응용 가치를 평가하였다. 이미 몇몇 보고 된 논문에서 금선련은 항암활성, 면역 활성, 간 보호 활성 및 지질대사의 약리학적 활성 등에 대한 연구가 되고 있지만 화장품 성분으로 효능들에 대한 연구는 알려져 있지 않다. 따라서 본 연구에서는 생물반응장치를 이용하여 조직배양된 금선련 추출물에 대하여 미백 및 항비만 관련한 효능 효과를 평가하였다. 실험 결과 조직배양된 금선련 추출물은 tyrosinase 활성 및 멜라닌 합성 억제 효과뿐만 아니라 지방 전구 세포의 지방세포로의 분화를 억제시킴으로써 세포 내 지질 축적을 억제하였다. 이러한 결과들은 피부보호를 위한 화장품 성분으로서 응용 가능성을 제공 할 수 있을 것으로 사료된다.

• 한국식품영양과학회지
• /
• 제45권12호
• /
• pp.1701-1707
• /
• 2016

본 연구에서는 C57BL/6J 마우스에 고지방 식이를 통한 비만을 유도시키며 동시에 잣송이 초임계 추출물을 식이에 첨가하여 8주간 식이 투여하여 항비만 식품 소재로서의 기능성을 알아보고자 하였다. 잣송이 초임계 추출물 20 mg/kg b.w.(HFD+PC low), 잣송이 초임계 추출물 100 mg/kg b.w. (HFD+PC high) 섭취군의 체중증가량은 고지방식이 유도 비만 대조군(HFD)에 비해 각각 유의적으로 감소하였고, 간, 백색 지방, 총 지방 무게의 변화량 역시 잣송이 초임계 추출물 섭취군이 HFD군에 비해 유의적으로 감소하였다. 실험동물의 혈청 지질 함량은 총콜레스테롤, 중성지방, LDL/VLDL 콜레스테롤, HDL 콜레스테롤이 HFD군에 비해 잣송이 초임계 추출물 섭취군에서 유의적으로 감소하였으나, HDL/LDL 비율을 계산한 결과에서는 잣송이 초임계 추출물 섭취군이 HFD군에 비해 유의적으로 증가하였음을 확인하였다. 실험동물군의 지방 조직에서 adipogenic transcription factor ($PPAR-{\gamma}$, SREBP, C/EBP)의 발현을 측정한 결과, 잣송이 초임계 추출물 섭취군이 HFD군에 비해 유의적으로 감소하였다. 또한, adipogenic enzyme(FAS, LPL)의 발현을 측정한 결과, 잣송이 초임계 추출물 섭취군이 HFD군에 비해 유의적으로 감소하였다. 이러한 결과로부터 잣송이 초임계 추출물이 항비만 효과를 가진 천연 기능성 식품의 개발에 있어 기초 자료로 활용할 수 있을 것으로 기대할 수 있다.

• 생명과학회지
• /
• 제25권1호
• /
• pp.62-67
• /
• 2015

본 연구는 바위수염 메탄올 추출물이 3T3-L1 지방세포의 분화 및 지방생성의 억제에 미치는 영향을 탐색하고자 하였다. 바위수염 메탄올 추출물의 농도에 따른 3T3-L1 세포의 성장에 미치는 영향을 MTT assay로 분석한 결과 $100{\sim}500{\mu}g/ml$l의 농도에서는 80% 이상의 비슷한 수준의 세포생존율을 보였다. 바위수염 메탄올 추출물을 처리하지 않고 분화를 유도하였을 경우에 세포질 내 지방구의 형성이 활발하게 유발되는 것으로 관찰되었으며, 바위수염 메탄올 추출물에 의한 지방구의 형성이 처리 농도 의존적으로 억제 되는 것을 확인하였다. 또한 바위수염 메탄올 추출물을 100, 300, $500{\mu}g/ml$ 처리한 후의 중성지방의 양은 바위수염 메탄올 추출물을 처리하지 않았을 때보다 35%, 42%, 76%로 농도 의존적으로 억제되는 것을 확인하였다. Insulin, dexamethasone 및 IBMX를 처리하여 분화를 유발하였을 경우 $PPAR{\gamma}$, $C/EBP{\alpha}$ 및 $C/EBP{\beta}$의 발현이 현저하게 증가되었으며, 이러한 분화유도 과정에서 바위수염 추출물을 처리한 결과 $100{\mu}g/ml$의 농도보다 $500{\mu}g/ml$의 처리군에서 $PPAR{\gamma}$, $C/EBP{\alpha}$ 및 $C/EBP{\beta}$의 발현이 단백질 수준에서 감소하였다. 본 연구결과 바위수염 메탄올 추출물은 lipid droplet 및 TG 생성을 감소시킴으로써 지방세포로의 분화를 억제시키는 것으로 나타나, 항비만 식품 소재로서의 개발 가능성이 있는 것으로 사료된다.

• 한국식품영양과학회지
• /
• 제39권6호
• /
• pp.927-931
• /
• 2010

본 연구에서는 농산 가공 폐기물로 버려지고 있는 포도씨 탈지박 methanol 추출물의 항비만 활성을 확인하고자 하였다. DGSE에 의한 TG 생성 저해효과를 측정하기 위해 시료를 3T3-L1 preadipocyte에 농도별(0, 25, 50, 100, 200 ${\mu}g/mL$)로 처리하면서 분화를 유도하였다. 실험 결과 DGSE는 지방세포내의 TG 생성과 GPDH 활성 및 주요 전사 인자인 PPAR$\gamma$ 및 C/EBP $\alpha$와 $\beta$의 발현을 농도 의존적으로 억제하는 것으로 나타났다. DGSE는 100 ${\mu}g/mL$의 비교적 낮은 농도에서도 우수한 지방 분화억제 활성을 나타내어 경제적이며 효과적인 항비만 기능성식품으로서의 활용가치가 기대된다.

• 한방비만학회지
• /
• 제22권1호
• /
• pp.30-37
• /
• 2022

Objectives: Adipogenesis is the process by which pre-adipocytes are differentiated into adipocytes. It also plays an important role in adipocyte formation and lipid accumulation. Ranunculus sceleratus (R. sceleratus) extracts are used for the treatment of various diseases such as hepatitis, jaundice, and tuberous lymphadenitis in oriental medicine. However, its effect on adipogenesis has not yet been studied. In this study, we investigated the effects of R. sceleratus on adipogenesis in 3T3-L1 cells. Methods: Cells were treated with 50, 100, and 200 ㎍/ml of R. sceleratus and cell viability was evaluated. To differentiate the 3T3-L1 preadipocytes, a 3-isobutyl-1-methylxanthine, dexamethasone, and insulin (MDI) solution were used. The accumulation of lipid droplets was determined by Oil Red O staining. The expression levels of adipogenesis-related proteins were also determined. Results: MDI solution differentiated the preadipocytes into adipocytes and accumulation of lipids was observed in the differentiated 3T3-L1 cells. Interestingly, the amount of lipid droplets was reduced after R. sceleratus treatment. In addition, the expression levels of key adipogenic transcription factors, such as CCAAT/enhancer-binding proteins-𝛼 (C/EBP-𝛼) and peroxisome proliferator-activated receptors-𝛾 (PPAR-𝛾) were also reduced after R. sceleratus treatment. Furthermore, R. sceleratus increased AMP-activated kinase (AMPK) phosphorylation and decreased sterol regulatory element-binding protein-1 expression. Conclusions: Our results showed that R. sceleratus reduced preadipocyte differentiation by inhibiting C/EBP-𝛼 and PPAR-𝛾 levels via the AMPK pathway. Therefore, we suggest that R. sceleratus may be potentially used as an anti-adipogenic agent.

• 대한한의학방제학회지
• /
• 제25권4호
• /
• pp.457-469
• /
• 2017

Obesity is one of the most serious health problem because it induced numerous metabolic syndrome and increases the incidence of various disease, including diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. In 3T3-L1 adipocytes, increases in reactive oxygens species (ROS) occur with lipid accumulation. NADPH oxidase, producing superoxide anion, may contribute to the development of obesity-associated insulin resistance and type 2 diabetes. In this study, we elucidated the effect of Chaenomeles sinensis koehne extract (CSE) against the development of obesity and the inhibition mechanisms in 3T3-L1 preadiocytes. CSE decreased triglyceride content and inhibited the expression of adipogenic transcription factors including peroxisome proliferator-activated receptor $(PPAR){\gamma}$, CCAT/enhancer binding protein $(C/EBP){\alpha}$ and sterol regulatory element-binding protein (SREBP-1). In addition, CSE highly increased antioxidant activity in a dose-dependent manner. CSE remarkably reduced intracellular ROS increase and NAD(P)H oxidase activity, NOX1, NOX4, Rac1 protein expression, and phosphorylation of p47phox and p67phox We also studied the effect of CSE on weight gain induced by high-fat diet. The oral treatment of CSE (500 mg/kg, body weight) in diet-induced obese (DIO) mice showed decrease in triglyceride and adipocyte size. Therefore, these results indicate that the effect of CSE on anti-obese effects, adipocyte differentiation and reducing triglyceride contents as well as adipocyte size in obese mice, may be associated with inhibition of NAD(P)H oxidase-induced ROS production and adipose transcription factors. These results showed the potential to inhibit the obesity by CSE treatment through controlling the activation of NAD(P)H oxidase in vitro and in vivo obese model.